Safety Lancet Market By Type (Push Button Safety Lancet, Pressure Activated Safety Lancet, and Side Button Safety Lancet), By End User (Hospitals & Clinics, Diagnostic Centers and Pathology Laboratories, Home Diagnostics, and Other), Industry Trends, Estimation & Forecast, 2023-2030

Market Overview

Safety lancets are retractable needles that prevent accidental pricks and reduce risk of infection. It has an in-built single-use system, avoiding the risk of cross-infection between patients. Safety lancet is designed to puncture and penetrate to a predetermined depth that is safe and specific to patient type. Safety Lancets provides Safe and Comfortable way for capillary blood sampling. Safety lancets use high speed, minimum pain, prevent error, have a comfortable grip and are ergonomically designed.

Safety Lancet market is estimated to reach $5.2 billion by 2030; growing at a CAGR of 11.9% till 2030

Industry Forces

The increasing prevalence of diabetes is boosting the global Safety Lancet market. For instance, According to the European Society of Cardiology, the prevalence of diabetes is 8.8% of the world population in 2017. The prevalence is expected to increase by 9.9% in 2045. The global population with diabetes was 424.9 million in 2017, with an estimate of a 48% increase to 628.6 million people for the year 2045. According to Centers for Disease Control (CDC), in the U.S, diabetes had risen to an estimated 30.3 million in 2017. About 90% of people have Type 2 diabetes, and 8% of people with Type 1 diabetes, and 2% of people have rarer types of diabetes. According to Diabetes UK, more than five million people will have diabetes in the UK by 2025. Increasing prevalence of chronic diseases, Rise in-home diagnostic blood tests are key driving factors of the market. However, the persistent problems of low product adoption in developing countries is a significant drawback of the safety lancet market. The final pricing structure of safety lancets with additional shipping costs is substantially high for emerging economies struggling to establish effective regional healthcare facilities. The lack of proper healthcare facilities in the developing countries restricts the wide adoption of safety lancets in such markets, thereby acting as market barriers to global growth. Growth in federal blood donation camps and non -profit medical camps would provide lucrative opportunities for the market in the coming years.

Market Segmentation

The global Safety Lancet market is mainly classified based on Type, End User. Type is further segmented into Push Button Safety Lancet, Pressure Activated Safety Lancet, Side Button Safety Lancet. Push-Button Safety Lancet is dominating the global Safety Lancet market by type. Push-Button Safety Lancets are single-use devices for capillary blood sampling dedicated to healthcare professionals. Push-Button Safety Lancets are designed to provide controlled needle depth. It is Safely designed to protect users from needle-stick injury, risk of infection for both patient and operators were eliminated. The partnership between companies to develop new advanced PushButton Safety Lancets is boosting the global Safety Lancets market. For instance, RPS Diagnostics (RPS), an Australian medical device company, Atomo Diagnostics, have entered into a commercial and development partnership to create next-generation FebriDx tests that are anticipated to transform the diagnosis of febrile acute respiratory infections (ARI) at the point-of-care. The FebriDx test utilize Atomo Diagnostics’ all-in-one rapid diagnostic test platform. The unique Atomo platform consolidates the test procedure into a single device. The platform incorporates an in-built safety lancet, calibrated blood collection and delivery system, and integrated push-button buffer delivery mechanism to help prevent user-related errors and improve test performance. Further by End User, the market is divided into Hospitals & Clinics, Diagnostic Centers And Pathology Laboratories, Home Diagnostics, Other.
 
Regional Analysis

Based on geography, the global Safety Lancet market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided in the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is segmented into India, China, Japan, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.

Europe is dominating the global Safety Lancet market. The wide application of safety lancets during blood monitoring tests is one of the factors impacting the gain in market traction of end-products in Europe. According to Centers for Disease Control and Prevention (CDC), approximately 7% of France’s adult population, which is 45 million have diabetes. According to international diabetes federation, there were over 7,476,800 cases of diabetes in Germany in 2017. Prevalence of diabetes in adults has increased to 12.2%. According to the National Institute for Health and care excellence around 400,000 adults in the UK are affected by type 1 diabetes, and around 27,000children and young people have either type 1 or type 2 diabetes.

Competitive Players

Key players operating in the Safety Lancet industry include F. Hoffmann-La Roche AG, Becton, Dickinson and Company, Terumo Medical Corporation, Bayer AG, HTL-STREFA S.A., Sarstedt AG & Co., Improve Medical Technology Co. Ltd, Smiths Medical, F.L. Medical SRL, B. Braun Melsungen AG.

Commercialization of approved products and formation of strategic collaborations are among the most followed business strategies of the key companies, with a focus on maintaining a competitive advantage over others. The companies are thus focused on product approvals and expansion of business activities on a global scale. For instance, on August 09, 2016, MediPurpose, a medical product manufacturer and master distributor, have received CE Mark clearance for SurgiLance Litesafety lancets.

Safety Lancet Market Key Segments

By Type
• Push-Button Safety Lancet
• Pressure Activated Safety Lancet
• Side Button Safety Lancet

By End User
• Hospitals & Clinics
• Diagnostic Centers And Pathology Laboratories
• Home Diagnostics
• Other
 
By Geography

• North America
o The U.S.
o Canada
o Mexico

• Europe
o U.K
o Germany
o France
o Italy
o Rest of Europe

• Asia Pacific
o India
o China
o Japan
o South Korea
o Rest of Asia Pacific

• South America
o Brazil
o Argentina
o Rest of South America

• Middle East & Africa
o GCC Countries
o Egypt
o South Africa
o Rest of Middle East & Africa

Key Global Safety Lancet Industry Players

• F. Hoffmann-La Roche AG
• Becton, Dickinson and Company
• Terumo Medical Corporation
• Bayer AG
• HTL-STREFA S.A.
• Sarstedt AG & Co.
• Improve Medical Technology Co. Ltd
• Smiths Medical
• F.L. Medical SRL
• B. Braun Melsungen AG

Table of Content

1. Market Introduction
1.1. Executive Summary
1.2. Market Definition
1.3. Market Scope

2. Research Methodology
2.1. Primary Research
2.2. Research Methodology
2.3. Assumptions & Exclusions
2.4. Secondary data sources

3. Safety Lancet Market Overview
3.1. Report Segmentation & Scope
3.2. Key Market Trend
3.3. Drivers
3.3.1. Increasing prevalence of diabetes
3.3.2. Increasing prevalence of chronic diseases
3.3.3. Rise in home diagnostic blood tests
3.4. Restraints
3.4.1. Low product adoption in developing countries
3.5. Opportunity
3.5.1. Growth in federal blood donation camps and non -profit medical camps
3.6. Porter’s Five Forces Analysis
3.6.1. Porter’s Five Forces Analysis
3.7. Market Share Analysis

4. Type Overview
4.1. Introduction
4.1.1. Market Size & Forecast
4.2. Push Button Safety Lancet
4.2.1. Market Size & Forecast
4.3. Pressure Activated Safety Lancet
4.3.1. Market Size & Forecast
4.4. Side Button Safety Lancet
4.4.1. Market Size & Forecast

5. End User Overview
5.1. Introduction
5.1.1. Market Size & Forecast
5.2. Hospitals & Clinics
5.2.1. Market Size & Forecast
5.3. Diagnostic Centers And Pathology Laboratories
5.3.1. Market Size & Forecast
5.4. Home Diagnostics
5.4.1. Market Size & Forecast
5.5. Other
5.5.1. Market Size & Forecast

6. Safety Lancet Market Regional Overview
6.1. Introduction
6.1.1. Market Size & Forecast
6.2. North America Safety Lancet Market
6.2.1. North America Market Size & Forecast, By Country
6.2.2. North America Market Size & Forecast, By Type
6.2.3. North America Market Size & Forecast, By End User
6.2.4. The U.S.
6.2.4.1. Market Size and Forecast
6.2.5. Canada
6.2.5.1. Market Size and Forecast
6.2.6. Mexico
6.2.6.1. Market Size and Forecast
6.3. Europe Safety Lancet Market
6.3.1. Europe Market Size & Forecast, By Country
6.3.2. Europe Market Size & Forecast, By Type
6.3.3. Europe Market Size & Forecast, By End User
6.3.4. Germany
6.3.4.1. Market Size and Forecast
6.3.5. France
6.3.5.1. Market Size and Forecast
6.3.6. UK
6.3.6.1. Market Size and Forecast
6.3.7. Italy
6.3.7.1. Market Size and Forecast
6.3.8. Spain
6.3.8.1. Market Size and Forecast
6.3.9. Rest of Europe
6.3.9.1. Market Size and Forecast
6.4. Asia-Pacific Safety Lancet Market
6.4.1. Asia-Pacific Market Size & Forecast, By Country
6.4.2. Asia-Pacific Market Size & Forecast, By Type
6.4.3. Asia-Pacific Market Size & Forecast, By End User
6.4.4. Japan
6.4.4.1. Market Size and Forecast
6.4.5. China
6.4.5.1. Market Size and Forecast
6.4.6. Australia
6.4.6.1. Market Size and Forecast
6.4.7. India
6.4.7.1. Market Size and Forecast
6.4.8. South Korea
6.4.8.1. Market Size and Forecast
6.4.9. Rest of Asia-Pacific
6.4.9.1. Market Size and Forecast
6.5. South America Safety Lancet Market
6.5.1. South America Market Size & Forecast, By Country
6.5.2. South America Market Size & Forecast, By Type
6.5.3. South America Market Size & Forecast, By End User
6.5.4. Brazil
6.5.4.1. Market Size and Forecast
6.5.5. Argentina
6.5.5.1. Market Size and Forecast
6.5.6. Rest of South America
6.5.6.1. Market Size and Forecast
6.6. Middle East & Africa Safety Lancet Market
6.6.1. Middle East & Africa Market Size & Forecast, By Country
6.6.2. Middle East & Africa Market Size & Forecast, By Type
6.6.3. Middle East & Africa Market Size & Forecast, By End User
6.6.4. GCC Countries
6.6.4.1. Market Size and Forecast
6.6.5. Egypt
6.6.5.1. Market Size and Forecast
6.6.6. South Africa
6.6.6.1. Market Size and Forecast
6.6.7. Rest of Middle East & Africa
6.6.7.1. Market Size and Forecast

7. Company Profile
7.1. F. Hoffmann-La Roche AG
7.1.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2. F. Hoffmann-La Roche AG Product Category, Application, and Specification
7.1.3. F. Hoffmann-La Roche AG Financial Performance (2016-2018)
7.1.4. Main Business/Business Overview
7.2. Becton, Dickinson and Company
7.3. Terumo Medical Corporation
7.4. Bayer AG
7.5. HTL-STREFA S.A.
7.6. Sarstedt AG & Co.
7.7. Improve Medical Technology Co. Ltd
7.8. Smiths Medical
7.9. F.L. Medical SRL
7.10. B. Braun Melsungen AG